Csaba P. Kövesdy

69.2k total citations · 7 hit papers
569 papers, 29.1k citations indexed

About

Csaba P. Kövesdy is a scholar working on Nephrology, Pulmonary and Respiratory Medicine and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Csaba P. Kövesdy has authored 569 papers receiving a total of 29.1k indexed citations (citations by other indexed papers that have themselves been cited), including 363 papers in Nephrology, 100 papers in Pulmonary and Respiratory Medicine and 94 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Csaba P. Kövesdy's work include Dialysis and Renal Disease Management (264 papers), Chronic Kidney Disease and Diabetes (110 papers) and Parathyroid Disorders and Treatments (88 papers). Csaba P. Kövesdy is often cited by papers focused on Dialysis and Renal Disease Management (264 papers), Chronic Kidney Disease and Diabetes (110 papers) and Parathyroid Disorders and Treatments (88 papers). Csaba P. Kövesdy collaborates with scholars based in United States, Hungary and Canada. Csaba P. Kövesdy's co-authors include Kamyar Kalantar‐Zadeh, Miklos Z. Molnar, Carmine Zoccali, Joel D. Kopple, Susan L. Furth, Elani Streja, Connie M. Rhee, Rajnish Mehrotra, John E. Anderson and Jun Lü and has published in prestigious journals such as New England Journal of Medicine, Circulation and SHILAP Revista de lepidopterología.

In The Last Decade

Csaba P. Kövesdy

546 papers receiving 28.5k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Obesity and Kidney Disease: Hidden Consequences of the Epidemic

2017 1.7k citations Csaba P. Kövesdy et al. American Journal of Nephrology profile →
Epidemiology of chronic kidney disease: an update 2022

2022 1.5k citations Csaba P. Kövesdy profile →
Survival predictability of time-varying indicators of bone disease in maintenance hemodialysis patients

2006 726 citations Kamyar Kalantar‐Zadeh, Deborah L. Regidor et al. profile →
Current and Potential Therapeutic Strategies for Hemodynamic Cardiorenal Syndrome

2015 479 citations Yoshitsugu Obi, Tae Hee Kim et al. profile →
A single number for advocacy and communication—worldwide more than 850 million individuals have kidney diseases

2019 338 citations Csaba P. Kövesdy et al. profile →
Kidney-Failure Risk Projection for the Living Kidney-Donor Candidate

2015 279 citations Csaba P. Kövesdy et al. profile →
Iron Deficiency in Chronic Kidney Disease: Updates on Pathophysiology, Diagnosis, and Treatment

2020 191 citations Csaba P. Kövesdy et al. profile →

Peers

Countries citing papers authored by Csaba P. Kövesdy

Since Specialization

Citations

This map shows the geographic impact of Csaba P. Kövesdy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Csaba P. Kövesdy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Csaba P. Kövesdy more than expected).

Fields of papers citing papers by Csaba P. Kövesdy

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Csaba P. Kövesdy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Csaba P. Kövesdy. The network helps show where Csaba P. Kövesdy may publish in the future.

Co-authorship network of co-authors of Csaba P. Kövesdy

This figure shows the co-authorship network connecting the top 25 collaborators of Csaba P. Kövesdy. A scholar is included among the top collaborators of Csaba P. Kövesdy based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Csaba P. Kövesdy. Csaba P. Kövesdy is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Ambient Temperature and Risk of Renal Colic: A Systematic Review and Meta-analysis 2025 ·Kidney Medicine ·Hoimonty Mazumder, (unknown), (unknown), Farah Farokhi, (unknown), (unknown), Fawaz Mzayek, Chunrong Jia, Matthew P. Smeltzer, Hongmei Zhang, Howard H. Chang, Robert L. Davis, Joshua S. Fu, Csaba P. Kövesdy, Md Mahbub Hossain, Abu Mohd Naser	0
2	The Association of Fibrate Use with Kidney Outcomes and Mortality 2025 ·Clinical Journal of the American Society of Nephrology ·Rina Takahashi, Jenny I. Shen, (unknown), (unknown), Tiane Dai, Anuja Shah, (unknown), (unknown), Keiichi Sumida, Fridtjof Thomas, (unknown), Csaba P. Kövesdy, Kamyar Kalantar‐Zadeh	1
3	Obesity and Metabolic Health in CKD 2025 ·Clinical Journal of the American Society of Nephrology ·Csaba P. Kövesdy	2
4	Anti–Tumor Necrosis Factor Therapy and Risk of Kidney Function Decline and Mortality in Inflammatory Bowel Disease 2024 ·JAMA Network Open ·Keiichi Sumida, Prabin Shrestha, (unknown), Fridtjof Thomas, Geeta Gyamlani, Elani Streja, Kamyar Kalantar‐Zadeh, Csaba P. Kövesdy	2
5	Impact of Thyroid Status on Incident Kidney Dysfunction and Chronic Kidney Disease Progression in a Nationally Representative Cohort 2024 ·Mayo Clinic Proceedings ·Amy S. You, Kamyar Kalantar‐Zadeh, Gregory A. Brent, Yoko Narasaki, (unknown), John J. Sim, Csaba P. Kövesdy, Danh V. Nguyen, Connie M. Rhee	8
6	Incident Diuretic Use and Subsequent Risk of Bone Fractures 2024 ·Mayo Clinic Proceedings ·Keiichi Sumida, Prabin Shrestha, (unknown), (unknown), Fridtjof Thomas, Elani Streja, Kamyar Kalantar‐Zadeh, Csaba P. Kövesdy	2
7	Comorbidities and neighborhood factors associated with prescription of sodium-glucose cotransporter protein-2 inhibitors and glucagon-like peptide-1 receptor agonists among medically underserved populations 2023 ·Journal of Managed Care & Specialty Pharmacy ·(unknown), (unknown), (unknown), Csaba P. Kövesdy, James E. Bailey, (unknown)	5
8	Development and Validation of a Prediction Model for Incident Hypothyroidism in a National Chronic Kidney Disease Cohort 2023 ·The Journal of Clinical Endocrinology & Metabolism ·Connie M. Rhee, Amy S. You, Yoko Narasaki, Gregory A. Brent, John J. Sim, Csaba P. Kövesdy, Kamyar Kalantar‐Zadeh, Danh V. Nguyen	2
9	The Role of Expert Opinion in Projecting Long-Term Survival Outcomes Beyond the Horizon of a Clinical Trial 2023 ·Advances in Therapy ·(unknown), Mario Ouwens, Andrew Briggs, Hiddo J.L. Heerspink, Carol A. Pollock, Roberto Pecoits‐Filho, Navdeep Tangri, Csaba P. Kövesdy, David C. Wheeler, Juan José García Sánchez	5
10	Real-World Phosphate Binder Use among Dialysis-Dependent Patients with CKD 2023 ·The Nephron journals/Nephron journals ·(unknown), (unknown), (unknown), (unknown), Jennifer Moore, Erika Szabó, Csaba P. Kövesdy	3
11	Serum Low-Density Lipoprotein Cholesterol and Cardiovascular Disease Risk Across Chronic Kidney Disease Stages (Data from 1.9 Million United States Veterans) 2022 ·The American Journal of Cardiology ·Leila Hashemi, Jui‐Ting Hsiung, (unknown), Melissa Soohoo, Nicholas Jackson, Elvira O. Gosmanova, Matthew J. Budoff, Csaba P. Kövesdy, Kamyar Kalantar‐Zadeh, Elani Streja	3
12	Prevalence of anaemia in adults with chronic kidney disease in a representative sample of the United States population: analysis of the 1999–2018 National Health and Nutrition Examination Survey 2022 ·Clinical Kidney Journal ·Csaba P. Kövesdy, Jill Davis, (unknown), Dustin J. Little	13
13	Hyperkalemia with Mineralocorticoid Receptor Antagonist Use in People with CKD 2021 ·Clinical Journal of the American Society of Nephrology ·Murray Epstein, Roberto Pecoits‐Filho, Catherine M. Clase, Manish M. Sood, Csaba P. Kövesdy	10
14	Racial and Ethnic Differences in Mortality Associated with Serum Potassium in Incident Peritoneal Dialysis Patients 2019 ·American Journal of Nephrology ·(unknown), Yoshitsugu Obi, Melissa Soohoo, Connie M. Rhee, Csaba P. Kövesdy, Kamyar Kalantar‐Zadeh, Elani Streja	8
15	Heart Failure Increases the Risk of Adverse Renal Outcomes in Patients With Normal Kidney Function 2017 ·Circulation Heart Failure ·(unknown), Santhosh Koshy, Miklos Z. Molnar, Fridtjof Thomas, Jun Lü, Kamyar Kalantar‐Zadeh, Csaba P. Kövesdy	52
16	Racial and Ethnic Differences in Mortality Associated with Serum Potassium in a Large Hemodialysis Cohort 2017 ·American Journal of Nephrology ·Tae Hee Kim, Connie M. Rhee, Elani Streja, Melissa Soohoo, Yoshitsugu Obi, Jason A. Chou, Amanda R. Tortorici, Vanessa Ravel, Csaba P. Kövesdy, Kamyar Kalantar‐Zadeh	13
17	Risks of Metformin in Type 2 Diabetes and Chronic Kidney Disease: Lessons Learned from Taiwanese Data 2016 ·The Nephron journals/Nephron journals ·Connie M. Rhee, Csaba P. Kövesdy, Kamyar Kalantar‐Zadeh	24
18	Changes in serum cystatin C, creatinine, and C‐reactive protein after cardiopulmonary bypass in patients with normal preoperative kidney function 2015 ·Nephrology ·(unknown), John‐Peder Escobar Kvitting, Csaba P. Kövesdy, Ingemar Cederholm, Zoltán Szabó	11
19	Hyponatremia, Hypernatremia, and Mortality in Patients With Chronic Kidney Disease With and Without Congestive Heart Failure 2012 ·Circulation ·Csaba P. Kövesdy, (unknown), Jun Lü, Sandra M. Malakauskas, Z. Jennie, Miklos Z. Molnar, Kamyar Kalantar‐Zadeh	214
20	Fluid Retention Is Associated With Cardiovascular Mortality in Patients Undergoing Long-Term Hemodialysis 2009 ·Circulation ·Kamyar Kalantar‐Zadeh, Deborah L. Regidor, Csaba P. Kövesdy, David Van Wyck, Suphamai Bunnapradist, Tamara B. Horwich, Gregg C. Fonarow	406

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact